Swiss Firm, Lonza Group, Acquires Genentech / Roche Facility in Vacaville for $1.2B

In a significant move that marks a new era for biotechnology and biomanufacturing in the Bay Area, Swiss-based Lonza Group has acquired a sprawling Genentech manufacturing facility in Vacaville, California, for $1.2 billion in cash. This acquisition not only underscores the growing demand for biologics manufacturing but also reflects the shifting dynamics within the biopharmaceutical […]